HDAC9 and Cerebral ischemia: We have previously shown that the HDAC inhibitor Trichostatin A provides robust neuroprotection against in vitro and in vivo models of cerebral ischemia, suggesting a role for histone acetylation in ischemic brain injury [7], [11].